Aspira Women’s Health Inc. Revenue from Contract with Customer, Excluding Assessed Tax
Aspira Women’s Health Inc. (AWHL) reported Revenue from Contract with Customer, Excluding Assessed Tax of $2.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- Aspira Women’s Health Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $2.05M, a 14.89% decline year-over-year.
- Aspira Women’s Health Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $1.97M, a 13.69% decline year-over-year.
- Aspira Women’s Health Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $2.23M, a 5.15% decline year-over-year.
- Aspira Women’s Health Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $2.31M, a 2.13% increase year-over-year.
- Aspira Women’s Health Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $9.22M, a 0.37% increase from fiscal 2024.
- Aspira Women’s Health Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $9.18M, a 0.31% increase from fiscal 2023.
- Aspira Women’s Health Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $9.15M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.05M 10-Q · filed 2026-08-14 | $4.01M 10-Q · filed 2026-08-14 | $6.24M derived: sum of 3 quarters · filed 2026-08-14 | $8.55M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.97M 10-Q · filed 2026-05-15 | $4.20M derived: sum of 2 quarters · filed 2026-05-15 | $6.50M derived: sum of 3 quarters · filed 2026-05-15 | $8.90M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $4.53M derived: sum of 2 quarters · filed 2026-04-01 | $6.94M derived: sum of 3 quarters · filed 2026-08-14 | $9.22M 10-K · filed 2026-04-01 |
| 2025-09-30 | $2.31M 10-Q · filed 2025-11-14 | $4.71M derived: sum of 2 quarters · filed 2026-08-14 | $6.99M 10-Q · filed 2025-11-14 | $9.34M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $2.40M 10-Q · filed 2026-08-14 | $4.68M 10-Q · filed 2026-08-14 | $7.03M derived: sum of 3 quarters · filed 2026-08-14 | $9.29M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.28M 10-Q · filed 2026-05-15 | $4.63M derived: sum of 2 quarters · filed 2026-05-15 | $6.88M derived: sum of 3 quarters · filed 2026-05-15 | $9.31M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $4.61M derived: sum of 2 quarters · filed 2026-04-01 | $7.03M derived: sum of 3 quarters · filed 2026-04-01 | $9.18M 10-K · filed 2026-04-01 |
| 2024-09-30 | $2.26M 10-Q · filed 2025-11-14 | $4.68M derived: sum of 2 quarters · filed 2025-11-14 | $6.83M 10-Q · filed 2025-11-14 | $8.96M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $2.42M 10-Q · filed 2025-08-13 | $4.58M 10-Q · filed 2025-08-13 | $6.71M derived: sum of 3 quarters · filed 2025-08-13 | $8.92M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $2.15M 10-Q · filed 2025-05-19 | $4.28M derived: sum of 2 quarters · filed 2025-05-19 | $6.50M derived: sum of 3 quarters · filed 2025-05-19 | $8.99M derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $4.35M derived: sum of 2 quarters · filed 2025-03-27 | $6.84M derived: sum of 3 quarters · filed 2025-03-27 | $9.15M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.22M 10-Q · filed 2024-11-19 | $4.71M derived: sum of 2 quarters · filed 2024-11-19 | $7.02M 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $2.49M 10-Q · filed 2024-08-13 | $4.81M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $2.32M 10-Q · filed 2024-05-15 |